Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin

Stock Information for JFT Strategies Fund

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About JFT Strategies Fund

Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales
Therma Bright Proposes to Amend Certain Warrants
Therma Bright Announces Share Consolidation
Therma Bright Inc. Announces Share Consolidation
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.